JVMRX | PYCGX | JVMRX / PYCGX | |
Total Expense Ratio | 0.75 | 0.98 | 77% |
Annual Report Gross Expense Ratio | 0.76 | 0.98 | 78% |
Fund Existence | 14 years | 27 years | - |
Gain YTD | -8.241 | -10.079 | 82% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 5000000 | 20% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 19.5B | 621M | 3,140% |
Annual Yield % from dividends | 0.94 | 1.44 | 65% |
Returns for 1 year | -13.69 | -10.17 | 135% |
Returns for 3 years | -6.57 | -12.42 | 53% |
Returns for 5 years | 47.61 | 29.07 | 164% |
Returns for 10 years | 24.21 | -6.79 | -357% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
TCIEX | 22.99 | 0.54 | +2.41% |
Nuveen International Eq Idx R6 | |||
BRXBX | 13.11 | 0.28 | +2.18% |
MFS Blended Research Intl Eq B | |||
HIAGX | 20.81 | 0.39 | +1.91% |
Hartford Disciplined Equity HLS IA | |||
AHSZX | 18.35 | 0.23 | +1.27% |
Alger Health Sciences Z | |||
MNMRX | 13.80 | 0.08 | +0.58% |
Manning & Napier Pro-Blend Mod Term R |